News Overview


Study on Mouse Hyperthermia Experiments Wins Dietrich Harder Master’s Thesis Award 2023

This year’s award went to Benjamin Kahlert, PhD student at the Radiation Oncology Department of the University Hospital of Erlangen.

PTW and DE.TEC.TOR sign distribution agreement for particle therapy quality assurance equipment

PTW has entered into a distribution agreement with DE.TEC.TOR, a Turin-based developer and manufacturer of high-precision quality assurance (QA) devices for particle therapy.

Erfolgreiches MR-gRT Entwicklungsprojekt

[German Language] Vom Bundesministerium für Wirtschaft und Klimaschutz gefördertes PTW-Entwicklungsprojekt "Präzise Dosimetrie bei MR-geführter Strahlentherapie" als „ZIM (Zentrales Innovationsprogramm Mittelstand) -Erfolgsbeispiel“ ausgewählt

Tissue-equivalent phantoms QRM, a PTW company since 2020

Learn more about the experts in the development of imaging and therapy phantoms made of soft tissue-, bone- and water-equivalent materials, solid resins, or PMMA.

Closer to the customer – PTW Benelux ready to serve customers in Norway

The dosimetry specialist PTW Freiburg GmbH (PTW) will serve customers in Norway directly through its branch office PTW Benelux to better address the growing needs of the Norwegian radiotherapy market. Operations will officially start on September 1, 2022.

Aktuelles aus der Presse

[German language] Wie schafft es ein Unternehmen, 100 Jahre zu werden?

EMP News Summer 2022

100 Years of Inventive Spirit at PTW: From Hammer Dosemeter to Today and Beyond

FDA clears PTW’s patient QA platform VERIQA

PTW has received approval from U.S. Food and Drug Administration (FDA) of its integrated software platform VERIQA for automated patient plan verification in radiotherapy QA.

Press release: PTW Netherlands will change its name to PTW Benelux

PTW Netherlands will assume the exclusive distribution rights for PTW products in Belgium and Luxembourg effective March 1, 2022. As a result, PTW Netherlands will change its name to PTW Benelux.

Find your local contact

Diese Seite existiert auch in Ihrer Sprache.
This page also exists in your language.
Sprache wechseln Change Language